Tag: Avianca

Browse our exclusive articles!

Lawyers Use AI Chatbot’s Fake Legal Research in Scandal.

Two lawyers in Manhattan federal court may face punishment after using an AI-powered chatbot called ChatGPT to support a case against Avianca Airlines. However, the chatbot produced fictitious legal research, causing concern among experts about the potential risks of AI. Microsoft invested $1bn in OpenAI, the company behind ChatGPT. The judge is yet to decide on sanctions.

Lawyer Utilizes ChatGPT to Prepare Lawsuit in the United States

New York lawyer apologizes for using OpenAI's chatbot, ChatGPT, to generate fictitious content for a lawsuit against Avianca. The false court precedents brought ridicule to his office and misled the court, unknowingly.

New York Lawyers Accuse ChatGPT of Tricking Them into Citing Inaccurate Legal Research

Two New York lawyers are held accountable for citing fake legal research in a court filing against Avianca, a Colombian airline. They blame ChatGPT, an AI tool, for suggesting non-existent cases. Microsoft invested $1 billion in OpenAI, the company behind ChatGPT. Learn more about emerging risks from AI in this article.

NYC judge scolds attorney for submitting a brief filled with unintelligible legal jargon created using ChatGPT bot, while lawyer blames the robot claiming it...

Personal injury lawyers reprimanded by a New York judge for using an AI-powered search engine to populate a legal brief with completely fake cases. A defendant warns of ethical dangers. Action against Steven Schwartz will be determined by the judge.

ChatGPT vs the Law: the Law Emerges Victorious

Avianca airline wins case against lawyer submitting fake legal cases. Lawyer Michael LoDuca blamed ChatGPT's bad advice for the fake cases which may lead to sanctions.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img